UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$191M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$157M |
| 3 |
Pfizer
PFE
|
+$139M |
| 4 |
3M
MMM
|
+$131M |
| 5 |
Meta Platforms (Facebook)
META
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALTR
Altera Corp
ALTR
|
+$288M |
| 2 |
Intercontinental Exchange
ICE
|
+$247M |
| 3 |
RKT
ROCK-TENN COMPANY CL-A
RKT
|
+$142M |
| 4 |
Yelp
YELP
|
+$140M |
| 5 |
Salesforce
CRM
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.28% |
| 2 | Financials | 14.69% |
| 3 | Technology | 14.25% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Caleres
CAL
$492M
| $658K | ﹤0.01% |
20,698
+2,900
| +16% | +$90.5K |
|
1852
Coeur Mining
CDE
$16.3B
| $657K | ﹤0.01% |
115,060
+40,831
| +55% | +$224K |
|
1853
Applied Industrial Technologies
AIT
$13.2B
| $654K | ﹤0.01% |
16,499
+1,100
| +7% | +$46.7K |
|
1854
Genesco
GCO
$434M
| $654K | ﹤0.01% |
9,899
+1,200
| +14% | +$82.3K |
|
|
SAFM
1855
DELISTED
Sanderson Farms Inc
SAFM
| $654K | ﹤0.01% |
8,699
+1,100
| +14% | +$87.3K |
|
|
MEG
1856
DELISTED
Media General, Inc
MEG
| $654K | ﹤0.01% |
39,600
+5,800
| +17% | +$96.4K |
|
1857
Forward Air
FWRD
$550M
| $653K | ﹤0.01% |
12,499
+1,200
| +11% | +$63.2K |
|
|
TFM
1858
DELISTED
THE FRESH MARKET, INC COM STK
TFM
| $653K | ﹤0.01% |
20,312
+2,900
| +17% | +$102K |
|
1859
Agree Realty
ADC
$9.51B
| $652K | ﹤0.01% |
22,368
+1,170
| +6% | +$36.2K |
|
1860
LiveRamp
RAMP
$2.3B
| $652K | ﹤0.01% |
37,097
+4,400
| +13% | +$79K |
|
|
FOE
1861
DELISTED
Ferro Corporation
FOE
| $651K | ﹤0.01% |
38,797
+3,300
| +9% | +$47.8K |
|
|
WX
1862
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $651K | ﹤0.01% |
15,400
-25,800
| -63% | -$1.09M |
|
1863
Evertec
EVTC
$1.85B
| $644K | ﹤0.01% |
30,303
+3,225
| +12% | +$71K |
|
|
RESI
1864
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $644K | ﹤0.01% |
38,200
+5,800
| +18% | +$109K |
|
1865
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| $643K | ﹤0.01% |
20,192
-920
| -4% | -$29.9K |
|
1866
Power Integrations
POWI
$3.33B
| $640K | ﹤0.01% |
28,342
+3,400
| +14% | +$85K |
|
1867
Scansource
SCSC
$1.16B
| $640K | ﹤0.01% |
16,816
+200
| +1% | +$7.94K |
|
1868
SouthState Bank Corp
SSB
$10.6B
| $639K | ﹤0.01% |
8,408
+1,171
| +16% | +$83.6K |
|
1869
iShares Russell 1000 ETF
IWB
$49.7B
| $637K | ﹤0.01% |
5,492
| – | – |
|
1870
Enpro
NPO
$7.06B
| $635K | ﹤0.01% |
11,099
+600
| +6% | +$37.8K |
|
|
QGENF
1871
DELISTED
QIAGEN NV
QGENF
| $635K | ﹤0.01% |
25,618
| – | – |
|
1872
St. Joe Company
JOE
$3.8B
| $634K | ﹤0.01% |
40,797
+2,100
| +5% | +$35.2K |
|
1873
ICU Medical
ICUI
$4.15B
| $631K | ﹤0.01% |
6,600
+100
| +2% | +$9.35K |
|
|
DOOR
1874
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $631K | ﹤0.01% |
+9,000
| New | +$618K |
|
|
SGY
1875
DELISTED
Stone Energy
SGY
| $631K | ﹤0.01% |
882
+15
| +2% | +$12.7K |
|
Similar funds
UBS AM's Q2 2015 Portfolio in Review
As of Q2 2015, UBS AM held 2,771 positions worth $104B, up 0.68% from $104B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS AM's Q2 2015 filing shows 148 new, 1,779 increased, 566 reduced and 77 closed positions. Its largest new stake was Viatris: 1,260,214 shares worth $85.5M. The largest sale was Altera Corp, an estimated $288M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
- UBS AM's largest Q2 2015 buy was Viatris: 1,260,214 shares worth $85.5M.
- UBS AM added most to Allergan plc in Q2 2015, an estimated $191M increase.
- UBS AM's biggest Q2 2015 reduction was Altera Corp, cutting an estimated $288M.
- UBS AM fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $78.3M.
- UBS AM's ten largest holdings make up 14% of its $104B portfolio in Q2 2015.
- UBS AM opened 148 new positions and closed 77 in Q2 2015.
- UBS AM's portfolio value rose 0.68% quarter-over-quarter to $104B.
Based on UBS AM's 13F filing for Q2 2015, filed 12 Aug 2015.